[Edaily Reporter Kwon Oh Seok ] On the 10th, the first trading day following a stock split, From Bio Co., Ltd.(377220)’s stock price soared to the daily upper limit.

According to MP Doctor on the 10th, as of 9:03 a.m., From Bio Co., Ltd. shares were trading at the daily price limit of 3,330 won, up 29.82% from the previous trading day.
Previously, in May, the company announced that it had decided to conduct a 5-for-1 stock consolidation, raising the par value of its shares from 100 won to 500 won. Trading was scheduled to be suspended from July 20 to August 9, and resumed on the 10th.
The company views the resumption of trading as the starting point for its “second leap forward” and plans to enhance corporate value through financial restructuring, securing future growth engines, and profitability-focused management.
From Bio Co., Ltd., an official stated, “The resumption of trading signifies more than just the restart of share trading; it marks our entry into a new phase of growth,” adding, “As improvements in our financial structure, growth in our biotech business, and improved performance at our subsidiaries are all becoming visible simultaneously, we are confident in enhancing our corporate value over the medium to long term.”
The official added, “In the second half of the year, we will focus on enhancing shareholder value by solidifying our improved performance and R&D achievements, as well as strengthening communication with the market through proactive investor relations (IR) activities.”